Cargando…
Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
Fibulin-3 has emerged as a promising novel biomarker in conforming or monitoring malignant pleural mesothelioma (MPM). This study sought to evaluate the diagnostic and prognostic efficacies of humoral fibulin-3 for MPM. Seven eligible publications comprising 468 MPM cases for diagnosis, and 138 for...
Autores principales: | Pei, Dongxu, Li, Yongwei, Liu, Xinwei, Yan, Sha, Guo, Xiaolan, Xu, Xiaona, Guo, Xiaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355074/ https://www.ncbi.nlm.nih.gov/pubmed/28103581 http://dx.doi.org/10.18632/oncotarget.14712 |
Ejemplares similares
-
Correction: Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
por: Pei, Dongxu, et al.
Publicado: (2018) -
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis
por: Kirschner, Michaela B, et al.
Publicado: (2015) -
Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis
por: Ren, Ran, et al.
Publicado: (2016) -
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014) -
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
por: Kovac, Viljem, et al.
Publicado: (2015)